Agile Therapeutics to Present at the 2014 Leerink Global Healthcare Conference
PRINCETON, N.J., Feb. 5, 2014 /PRNewswire/ — Agile Therapeutics, Inc., a specialty pharmaceutical company focused on women’s health, announced today that Mr. Al Altomari, President and Chief Executive Officer, will present at the 2014 Leerink Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Wednesday, February 12, 2014, at 10:40 a.m. ET.
About Agile Therapeutics
Agile Therapeutics is a specialty pharmaceutical company focused on women’s health that is currently developing innovative contraceptive products based on Agile’s proprietary and patented transdermal technology called Skinfusion(®). Skinfusion consists of both an active and a peripheral adhesive system designed to allow stable drug delivery and dependable adhesion over seven days. The Company’s lead investigational product, Twirla(TM)(AG200-15), is a once-weekly contraceptive patch designed to provide convenience and compliance that is currently in late stage clinical development. Agile has an additional pipeline of product candidates consisting of innovative contraceptive patch regimens and a progestin-only contraceptive patch (AG890) that utilize Skinfusion. For more information, please visit http://www.agiletherapeutics.com
SOURCE Agile Therapeutics, Inc.